WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Year in Review 2024 - NSCLC Perioperative Therapy

Oncology 2024 Year in Review

B. Halmos

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

Total Health

D. Carbone

The Non-Invasive Diagnosis of Lung Cancer

Memorial Sloan Kettering Cancer Center

G. Rocco

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Nodules and Lung Cancer Screening

Fox Chase Cancer Center

R. Kumar

Adjuvant & Neoadjuvant Therapy in Early NSCLC With Actionable Genomi…

Fox Chase Cancer Center

J. Reuss

Thoracic Malignancies From an Interventional Pulmonologist's Perspec…

Fox Chase Cancer Center

C. Manley

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

An Update of ADC Toxicities in Solid Tumors

OncoAlert

M. Lustberg

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Surgical Advances in Lung Cancer

University of Colorado Department of Medicine

S. Randhawa

Current Landscape of Neoadjuvant, Perioperative, and Adjuvant IO in …

UCLA Health

J. Lee

Year in Review 2024 - Targeted Therapy for NSCLC

Nebraska Oncology Society

J. Murray

Lung Cancer Screening Guidelines and Care

Yale Cancer Center

E. Winer, L. T Tanoue

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles

Biopsies in Lung Cancer: Tumor vs. Liquid

GRACE

J. Luo

Overview of Lung Cancer Classification and Rare Alterations

Lung Cancer Europe (LuCE)

B. Besse

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Ther…

Insights from 2024 WCLC

J. Von Der Thusen

The Future of Lung Cancer Treatment: What’s on the Horizon?

GRACE

J. Rotow, I. Dagogo-Jack, M. Shields, A. Cooper, A. Qin